MARX Biotech Co (ROCO:7731) Debt-to-Equity : 0.03 (As of Jun. 2024)

View and export this data going back to 2024. Start your Free Trial

What is MARX Biotech Co Debt-to-Equity?

MARX Biotech Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was NT$5.4 Mil. MARX Biotech Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was NT$2.3 Mil. MARX Biotech Co's Total Stockholders Equity for the quarter that ended in Jun. 2024 was NT$246.2 Mil. MARX Biotech Co's debt to equity for the quarter that ended in Jun. 2024 was 0.03.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for MARX Biotech Co's Debt-to-Equity or its related term are showing as below:

ROCO:7731' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.03 Max: 0.23
Current: 0.03

During the past 4 years, the highest Debt-to-Equity Ratio of MARX Biotech Co was 0.23. The lowest was 0.01. And the median was 0.03.

ROCO:7731's Debt-to-Equity is ranked better than
92.57% of 552 companies
in the Healthcare Providers & Services industry
Industry Median: 0.48 vs ROCO:7731: 0.03

MARX Biotech Co Debt-to-Equity Historical Data

The historical data trend for MARX Biotech Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MARX Biotech Co Debt-to-Equity Chart

MARX Biotech Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

N/A

0.03

0.23

0.01

MARX Biotech Co Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Debt-to-Equity	Get a 7-Day Free Trial			N/A	0.23	0.09	0.01	0.03

Competitive Comparison of MARX Biotech Co's Debt-to-Equity

For the Pharmaceutical Retailers subindustry, MARX Biotech Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MARX Biotech Co's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MARX Biotech Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where MARX Biotech Co's Debt-to-Equity falls into.

MARX Biotech Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

MARX Biotech Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.262	+	0.622)	/	292.991
	=	0.01

MARX Biotech Co's Debt to Equity Ratio for the quarter that ended in Jun. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(5.444	+	2.298)	/	246.236
	=	0.03

MARX Biotech Co (ROCO:7731) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

MARX Biotech Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of MARX Biotech Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

MARX Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MARX Biotech Co Ltd (ROCO:7731) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

5th Floor, No. 655, Bannan Road, Zhonghe district, New Taipei, TWN

Website

https://www.marxbiotech.com

MARX Biotech Co Ltd is a retail company which has developed an O2O and OMO full-channel layout in the online Internet platform and cosmeceutical retail market, and has successfully established itself in the market and Build trust and operational growth on the channel side. It has has established more than three thousand large and small cosmeceutical pharmacies in Taiwan, including: Dashu Pharmacy, Dingding Pharmacy, Cosmed, Watsons, Spring Pharmacy, New Gaoqiao Pharmacy, Anlier Pharmacies, etc.

MARX Biotech Co Headlines

No Headlines